• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Anaplastic Astrocytoma

Anaplastic Astrocytoma - 216 Studies Found

Active, not recruiting : Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
: Brain and Central Nervous System Tumors
: 2006-01-10
:
  • Drug: arsenic trioxide Arsenic

Terminated : Melphalan With BBBD in Treating Patients With Brain Malignancies
:
  • Brain and Central Nervous System Tumors
  • Lymphoma
  • Metastati
    : 2005-11-11
    : Drug: Melphalan All levels: Every 4 weeks for up to one ye
Completed : Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
: Brain and Central Nervous System Tumors
: 2005-07-26
: Drug: Erlotinib hydrochloride This study has 2 components: a Phase I component which estimated the MTD a
Completed : CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas
: Brain and Central Nervous System Tumors
: 2003-12-10
: Drug: CC-8490
Completed : Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
: Brain and Central Nervous System Tumors
: 2002-10-03
:
  • Drug: celecoxib
  • Drug: cyclophosphamide

Withdrawn : Phase I/II Cabazitaxel for Recurrent Malignant Glioma
: Brain Cancer
: 2012-11-30
: Drug: Cabazitaxel Phase I Starting Dose: Cohort 1A) 25 mg/
Completed : G207 Followed by Radiation Therapy in Malignant Glioma
: Malignant Glioma
: 2005-09-08
: Drug: G207 1 x 10E9 plaque forming units, administered by stereotactic injections into the tumor (single
Completed : Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
:
  • Brain and Central Nervous System Tumors
  • Infection

: 2009-10-21
:
  • Other: laboratory biomarker analysis
  • Other

Completed : Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
:
  • Brain and Central Nervous System Tumors
  • Psychosocial Effects of Cancer and Its Treatment : 2006-09-13
    :
    • Behavioral: exercise intervention

Completed : Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma
:
  • Brain Tumors
  • Osteoporosis
  • Central Nervous System(CNS)Malig
    : 2006-03-09
    : Drug: IV Zometa Zometa will be given at 4 mg intravenously over 15 minutes every 3 months for 1 year.
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.